Mechanisms of Drug-Induced Tolerance in Mycobacterium tuberculosis
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Successful treatment of tuberculosis (TB) can be hampered by Mycobacterium tuberculosis populations that are temporarily able to survive antibiotic pressure in the absence of drug resistance-conferring mutations, a phenomenon termed drug tolerance. We summarize findings on M. tuberculosis tolerance published in the past 20 years. Key M. tuberculosis responses to drug pressure are reduced growth rates, metabolic shifting, and the promotion of efflux pump activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Distinguishing between resistance, tolerance and persistence to antibiotic treatment
Brauner, A., Fridman, O., Gefen, O., & Balaban, N. Q. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.34 · Cited by 1,612
Definitions and guidelines for research on antibiotic persistence
Balaban, N. Q., Helaine, S., Lewis, K., Ackermann, M., Aldridge, B., Andersson, D. I., Brynildsen, M. P., Bumann, D., Camilli, A., Collins, J. J., et al. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0196-3 · Cited by 1,313 · cited 4×
“genetically encoded, and does not affect the MIC but changes the MDK99, the minimum duration of treatment that kills 99% of the mycobacterial population (7, 21, 24).”
BackgroundInfluentialBoeree, M. J., Heinrich, N., Aarnoutse, R., Diacon, A. H., Dawson, R., Rehal, S., Kibiki, G. S., Churchyard, G., Sanne, I., Ntinginya, N. E., et al. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)30274-2 · Cited by 379
Inhibition of synthesis of arabinogalactan by ethambutol in Mycobacterium smegmatis
Takayama, K., & Kilburn, J. O. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.9.1493 · Cited by 369
Metabolic Regulation of Mycobacterial Growth and Antibiotic Sensitivity
Baek, S.-H., Li, A. H., & Sassetti, C. M. (2011) · PLoS Biology · doi:10.1371/journal.pbio.1001065 · Cited by 324
Altered NADH/NAD + Ratio Mediates Coresistance to Isoniazid and Ethionamide in Mycobacteria
Vilchèze, C., Weisbrod, T. R., Chen, B., Kremer, L., Hazbón, M. H., Wang, F., Alland, D., Sacchettini, J. C., & Jacobs, W. R. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.708-720.2005 · Cited by 284 · cited 1×
“tuberculosis employs, where a fixed mutation in the NADH dehydrogenase-encoding ndh gene confers irreversible resistance to INH (99).”
BackgroundStructures of cell wall arabinosyltransferases with the anti-tuberculosis drug ethambutol
Zhang, L., Zhao, Y., Gao, Y., Wu, L., Gao, R., Zhang, Q., Wang, Y., Wu, C., Wu, F., Gurcha, S. S., et al. (2020) · Science · doi:10.1126/science.aba9102 · Cited by 173 · cited 1×
“Ethambutol (EMB) exerts its bacteriostatic activity by inhibiting the production of arabinogalactan, a mycobacterial cell wall constituent (110, 111).”
BackgroundLee, J. J., Lee, S.-K., Song, N., Nathan, T. O., Swarts, B. M., Eum, S.-Y., Ehrt, S., Cho, S.-N., & Eoh, H. (2019) · Nature Communications · doi:10.1038/s41467-019-10975-7 · Cited by 122
Nguyen, L., Chinnapapagari, S., & Thompson, C. J. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.19.6603-6611.2005 · Cited by 108
Cited by
Are all antibiotic persisters created equal?
Shultis, M. W., Mulholland, C. V., & Berney, M. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.933458 · Cited by 19
“antitoxin system utilization, and efflux pumps are used to describe the mechanisms of both persistence and tolerance, [reviewed elsewhere in (Boldrin et al., 2020; Goossens et al., 2020)].”
Background
Metadata
- Authors
- Goossens, S. N., Sampson, S. L., & Van Rie, A.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2020-12-16
- Volume
- 34
- Issue
- 1
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- OpenAlex
- W3092665952
- Cited by
- 180
- References
- 9
- FWCI
- 2.32
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mechanisms of Drug-Induced Tolerance in Mycobacterium tuberculosis. https://app.cochat.ai/papers/10.1128/cmr.00141-20
- The paper
- Goossens, S. N., Sampson, S. L., & Van Rie, A. (2020). Mechanisms of Drug-Induced Tolerance in Mycobacterium tuberculosis. Clinical Microbiology Reviews. https://doi.org/10.1128/cmr.00141-20
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.